1,374 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
NVS Novartis AG $85.13 $197.65B N/A
Article Searches
Key Factors to Look Out for in Celgene's (CELG) Q1 Results http://www.zacks.com/stock/news/257633/key-factors-to-look-out-for-in-celgenes-celg-q1-results?cid=CS-ZC-FT-257633 Apr 25, 2017 - Apart from the usual earnings and revenue numbers, investors will be focused on the performance of Celgene's (CELG) key products and its pipeline progress.
Will Low Pricing for Siliq Be Enough to Help Valeant Turn Things Around? https://www.fool.com/investing/2017/04/25/will-low-pricing-for-siliq-be-enough-to-help-valea.aspx?source=iedfolrf0000001 Apr 25, 2017 - Valeant is undercutting Novartis and Lilly with its pricing of psoriasis drug Siliq. How much will the strategy help?
Koninklijke Philips NV 2017 Q1 - Results - Earnings Call Slides https://seekingalpha.com/article/4064602-koninklijke-philips-nv-2017-q1-results-earnings-call-slides?source=feed_all_articles Apr 24, 2017 - The following slide deck was published by Koninklijke Philips NV in conjunction with their 2017 Q1 earnings call.
Koninklijke Philips NV reports Q1 results https://seekingalpha.com/news/3258846-koninklijke-philips-nv-reports-q1-results?source=feed_news_all Apr 24, 2017 - Koninklijke Philips NV (NYSE:PHG): Q1 EPS of €0.25Revenue of €5.72B (+3.6% Y/Y)Shares +1.29% PM.Press Release
Drug Stocks Q1 Earnings Releases on Apr 25: LLY, BIIB, NVS http://www.zacks.com/stock/news/257367/drug-stocks-q1-earnings-releases-on-apr-25-lly-biib-nvs?cid=CS-ZC-FT-257367 Apr 24, 2017 - As the Q1 earnings season gets in full swing this week, we believe this quarter is on track to see the highest growth in almost three years.
Should Gilead Sciences Be Worried About Allergan? https://www.fool.com/investing/2017/04/23/should-gilead-sciences-be-worried-about-allergan.aspx?source=iedfolrf0000001 Apr 23, 2017 - Gilead Sciences might want to pay attention to Allergan's aggressive expansion of its NASH program.
Pier 88 Investment Partners Llc Buys Welltower, Wells Fargo, Anthem, Sells Hess, Mobileye NV, ... http://www.gurufocus.com/news/508212/pier-88-investment-partners-llc-buys-welltower-wells-fargo-anthem-sells-hess-mobileye-nv-akamai-technologies Apr 21, 2017 - Pier 88 Investment Partners Llc Buys Welltower, Wells Fargo, Anthem, Sells Hess, Mobileye NV, Akamai Technologies, Stocks: HCNPRI,WFCPRL,ANTX,DCUC,EXCU,NPTN,TWX,PI,NEWR,CALD, release date:Apr 21, 2017
United States Steel & Carnegie Pension Fund Buys Unilever NV, Enbridge, Fortune Brands Home ... http://www.gurufocus.com/news/507950/united-states-steel--carnegie-pension-fund-buys-unilever-nv-enbridge-fortune-brands-home--security-sells-spdr-sp-500-international-paper-co-unilever-plc Apr 21, 2017 - United States Steel & Carnegie Pension Fund Buys Unilever NV, Enbridge, Fortune Brands Home & Security, Sells SPDR S&P 500, International Paper Co, Unilever PLC, Stocks: ENB,FBHS,UN,IP,SE,CHKP,DIS,, release date:Apr 21, 2017
What's in Store for GlaxoSmithKline (GSK) in Q1 Earnings? http://www.zacks.com/stock/news/257310/whats-in-store-for-glaxosmithkline-gsk-in-q1-earnings?cid=CS-ZC-FT-257310 Apr 21, 2017 - GlaxoSmithKline plc (GSK) is scheduled to report first-quarter 2017 results on Apr 26 before market opens. Last quarter, the company delivered a positive earnings surprise of 14.04%.
Novartis (NVS) Q1 Earnings: Will the Stock Disappoint? http://www.zacks.com/stock/news/257089/novartis-nvs-q1-earnings-will-the-stock-disappoint?cid=CS-ZC-FT-257089 Apr 20, 2017 - Swiss pharmaceutical company Novartis AG (NVS) is scheduled to report first-quarter 2017 results on Apr 25.
<<<Page 124>